Publicaciones en las que colabora con ALBERTO BARRIENTOS GUZMÁN (100)

2016

  1. New strategy of tacrolimus administration in animal model based on tacrolimus-loaded microspheres

    Transplant Immunology, Vol. 36, pp. 9-13

  2. Serum biomarkers in uncontrolled no heart-beating donors may identify kidneys that will never work after transplantation

    Journal of Nephrology, Vol. 29, Núm. 1, pp. 119-127

2012

  1. Changes by tacrolimus of the rat aortic proteome: Involvement of endothelin-1

    Transplant Immunology, Vol. 26, Núm. 4, pp. 191-200

  2. Everolimus as primary immunosuppression in kidney transplantation: Experience in conversion from calcineurin inhibitors

    Transplantation, Vol. 93, Núm. 4, pp. 398-405

  3. Limited-sampling strategy for mycophenolic acid in renal transplant recipients reciving enteric-coated mycophenolate sodium and tacrolimus

    Therapeutic Drug Monitoring, Vol. 34, Núm. 3, pp. 298-305

  4. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation

    Transplantation Proceedings

  5. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 11, pp. 4227-4235

2011

  1. Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients

    Transplant Infectious Disease, Vol. 13, Núm. 6, pp. 584-591

2010

  1. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: Pharmacodynamic and microbiological aspects

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 2, pp. 103-108

  2. Different protein expression in normal and dysfunctional platelets from uremic patients

    Journal of Nephrology, Vol. 23, Núm. 1, pp. 90-101

  3. H1N1 2009 influenza in kidney transplant patients

    Transplantation

  4. Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2902-2904

  5. Protective effect of Vitamin C on vascular damage and arterial hypertension induced by low-level mercury and lead exposure

    Handbook of Vitamin C Research: Daily Requirements, Dietary Sources and Adverse Effects (Nova Science Publishers, Inc.), pp. 329-342

2009

  1. Graft Outcome and Mycophenolic Acid Trough Level Monitoring in Kidney Transplantation

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2102-2103

  2. Inadequate Mycophenolic Acid Exposure and Acute Rejection in Kidney Transplantation

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2104-2105

  3. Intracellular ATP Levels in CD4+ Lymphocytes Are a Risk Marker of Rejection and Infection in Renal Graft Recipients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2106-2108

  4. Protective effect of vitamin C on vascular damage and arterial hypertension induced by low-level mercury and lead exposure

    Handbook of Vitamin C Research: Daily Requirements, Dietary Sources and Adverse Effects (Nova Science Publishers, Inc.), pp. 329-341

  5. Sirolimus and Everolimus Induced Pneumonitis in Adult Renal Allograft Recipients: Experience in a Center

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2163-2165

  6. The Prevalence of Uridine Diphosphate-Glucuronosyltransferase 1A9 (UGT1A9) Gene Promoter Region Single-Nucleotide Polymorphisms T-275A and C-2152T and Its Influence on Mycophenolic Acid Pharmacokinetics in Stable Renal Transplant Patients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2313-2316

2008

  1. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients

    Proteomics - Clinical Applications, Vol. 2, Núm. 9, pp. 1300-1312